Pathogenicity of clinical oxa-48 isolates and impact of the oxa-48 incl plasmid on virulence and bacterial fitness

  • OXA-48 is the most common carbapenemase in Enterobacterales in Germany and one of the most frequent carbapenemases worldwide. Several reports have associated blaOXA–48 with a virulent host phenotype. To challenge this hypothesis, 35 OXA-48-producing clinical isolates of Escherichia coli (n = 15) and Klebsiella pneumoniae (n = 20) were studied in vitro, in vivo employing the Galleria mellonella infection model and by whole-genome sequencing. Clinical isolates belonged to 7 different sequence types (STs) in E. coli and 12 different STs in K. pneumoniae. In 26/35 isolates blaOXA–48 was located on a 63 kb IncL plasmid. Horizontal gene transfer (HGT) to E. coli J53 was high in isolates with the 63 kb IncL plasmid (transconjugation frequency: ∼103/donor) but low in isolates with non-IncL plasmids (<10–6/donor). Several clinical isolates were both highly cytotoxic against human cells and virulent in vivo. However, 63 kb IncL transconjugants generated from these highly virulent isolates were not more cytotoxic or virulent when compared to the recipient strain. Additionally, no genes associated with virulence were detected by in silico analysis of OXA-48 plasmids. The 63 kb plasmid was highly stable and did not impair growth or fitness in E. coli J53. In conclusion, OXA-48 clinical isolates in Germany are diverse but typically harbor the same 63 kb IncL plasmid which has been reported worldwide. We demonstrate that this 63 kb IncL plasmid has a low fitness burden, high plasmid stability and can be transferred by highly efficient HGT which is likely the cause of the rapid dissemination of OXA-48 rather than the expansion of a single clone or gain of virulence.

Download full text files

Export metadata

Metadaten
Author:Axel HamprechtORCiDGND, Julian Sommer, Matthias WillmannORCiDGND, Christina Brender, Yvonne Stelzer, Felix F. Krause, Tsvetan Tsvetkov, Florian Wild, Sara Riedel-Christ, Julia Kutschenreuter, Can Imirzalioglu, Aitor Gonzaga, Ulrich Nübel, Stephan GöttigORCiDGND
URN:urn:nbn:de:hebis:30:3-518187
DOI:https://doi.org/10.3389/fmicb.2019.02509
ISSN:1664-302X
Pubmed Id:https://pubmed.ncbi.nlm.nih.gov/31736929
Parent Title (English):Frontiers in microbiology
Publisher:Frontiers Media
Place of publication:Lausanne
Contributor(s):Yuji Morita
Document Type:Article
Language:English
Year of Completion:2019
Date of first Publication:2019/11/01
Publishing Institution:Universitätsbibliothek Johann Christian Senckenberg
Release Date:2019/12/02
Tag:IncL; OXA-48; carbapenemases; fitness; plasmid; virulence; β-lactamases
Volume:10
Issue:Art. 2509
Page Number:12
First Page:1
Last Page:12
Note:
Copyright © 2019 Hamprecht, Sommer, Willmann, Brender, Stelzer, Krause, Tsvetkov, Wild, Riedel-Christ, Kutschenreuter, Imirzalioglu, Gonzaga, Nübel and Göttig. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
HeBIS-PPN:457694130
Institutes:Medizin / Medizin
Dewey Decimal Classification:6 Technik, Medizin, angewandte Wissenschaften / 61 Medizin und Gesundheit / 610 Medizin und Gesundheit
Sammlungen:Universitätspublikationen
Open-Access-Publikationsfonds:Medizin
Licence (German):License LogoCreative Commons - Namensnennung 4.0